Bionovate Technologies Corp (BIIO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 237.38 Thousand USD | 28.06% |
| 2019 | 185.37 Thousand USD | -17.5% |
| 2018 | 224.69 Thousand USD | -16.53% |
| 2017 | 269.17 Thousand USD | 41.37% |
| 2016 | 190.4 Thousand USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q1 | 237.52 Thousand USD | 0.06% |
| 2020 Q2 | 200.84 Thousand USD | 6.15% |
| 2020 FY | 237.38 Thousand USD | 28.06% |
| 2020 Q3 | 231.08 Thousand USD | 15.06% |
| 2020 Q1 | 189.21 Thousand USD | 2.07% |
| 2020 Q4 | 237.38 Thousand USD | 2.73% |
| 2019 Q2 | 244.15 Thousand USD | 8.42% |
| 2019 FY | 185.37 Thousand USD | -17.5% |
| 2019 Q4 | 185.37 Thousand USD | 1.09% |
| 2019 Q1 | 225.18 Thousand USD | 0.22% |
| 2019 Q3 | 183.37 Thousand USD | -24.89% |
| 2018 Q4 | 224.69 Thousand USD | 34.89% |
| 2018 FY | 224.69 Thousand USD | -16.53% |
| 2018 Q3 | 166.57 Thousand USD | 4.06% |
| 2018 Q2 | 160.07 Thousand USD | 11.97% |
| 2018 Q1 | 142.95 Thousand USD | -46.89% |
| 2017 Q2 | 46.07 Thousand USD | 1.4% |
| 2017 Q1 | 45.43 Thousand USD | -76.14% |
| 2017 FY | 269.17 Thousand USD | 41.37% |
| 2017 Q4 | 269.17 Thousand USD | 678.21% |
| 2017 Q3 | 34.58 Thousand USD | -24.93% |
| 2016 Q2 | 9057.00 USD | 0.0% |
| 2016 FY | 190.4 Thousand USD | 0.0% |
| 2016 Q3 | 27.67 Thousand USD | 205.51% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | 190.4 Thousand USD | 588.12% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | 449.48 Thousand USD | 100.0% |
| Manhattan Scientifics, Inc. | 60 Thousand USD | 100.0% |
| Össur hf. | 467.73 Million USD | 100.0% |
| QHSLab, Inc. | 1.78 Million USD | 100.0% |
| Wellstar International, Inc. | 51.36 Million USD | 100.0% |
| Össur hf. | 467.73 Million USD | 100.0% |
| CVR Medical Corp. | - USD | NaN% |
| Escalon Medical Corp. | 524.71 Thousand USD | 100.0% |
| Aurora Spine Corporation | 2.67 Million USD | 100.0% |
| BrainsWay Ltd. | 471 Thousand USD | 100.0% |
| Lattice Biologics Ltd. | - USD | NaN% |
| BioElectronics Corporation | 14.83 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 27.81 Million USD | 100.0% |
| Vivos Inc. | - USD | NaN% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | 100.0% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | 100.0% |
| Zecotek Photonics Inc. | 3.22 Million USD | 100.0% |
| Avitar, Inc. | 5.26 Million USD | 100.0% |
| Nanomix Corporation | 11.4 Million USD | 100.0% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | 100.0% |
| Theraclion SA | 1.95 Million EUR | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Positron Corporation | 1.78 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | 1.69 Million USD | 100.0% |
| Lombard Medical, Inc. | 32.29 Million USD | 100.0% |
| ALR Technologies Inc. | 19.26 Million USD | 100.0% |
| Stratec SE | 156.16 Million USD | 100.0% |
| Vycor Medical, Inc. | 1.11 Million USD | 100.0% |
| Heart Tronics, Inc. | 209.28 Thousand USD | 100.0% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 100.0% |
| VMS Rehab Systems, Inc. | 133.52 USD | 100.0% |
| NewCardio, Inc. | 3 Million USD | 100.0% |
| Guided Therapeutics, Inc. | 2.05 Million USD | 100.0% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | 100.0% |
| Odyssey Group International, Inc. | 2.14 Million USD | 100.0% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | 100.0% |
| Wellness Center USA, Inc. | 4.04 Million USD | 100.0% |
| SANUWAVE Health, Inc. | 31.94 Million USD | 100.0% |
| IR-Med Inc. | 161 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | 100.0% |
| Polarean Imaging plc | 216.38 Thousand USD | 100.0% |
| United American Healthcare Corporation | - USD | NaN% |
| ECGI Holdings, Inc. | 3.17 Million USD | 100.0% |
| Nu-Med Plus, Inc. | 100 Thousand USD | 100.0% |
| Capital Group Holdings, Inc. | 4944.00 USD | 100.0% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | 100.0% |
| Medical Supply International USA, Inc. | 227 Thousand USD | 100.0% |
| Urologix, Inc. | 5.33 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | 100.0% |
| Nexeon MedSystems Inc. | 4.21 Million USD | 100.0% |
| SS Innovations International, Inc. | 8.21 Million USD | 100.0% |
| Qualis Innovations, Inc. | 9102.00 USD | 100.0% |
| Smith & Nephew plc | 3.07 Billion USD | 100.0% |
| NIOX Group Plc | 1.4 Million USD | 100.0% |
| Fuse Medical, Inc. | 1.99 Million USD | 100.0% |
| Broncus Holding Corporation | 2.35 Million USD | 100.0% |
| Brain Scientific Inc. | 2.86 Million USD | 100.0% |
| Pressure BioSciences, Inc. | 22.75 Million USD | 100.0% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | 100.0% |